The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 30, 2018
Filed:
Jan. 04, 2016
Applicant:
Siamab Therapeutics, Inc., Newton, MA (US);
Inventors:
Julie DeSander, Arlington, MA (US);
Jeffrey Behrens, Newton, MA (US);
Alexey Alexandrovich Lugovskoy, Woburn, MA (US);
Assignee:
SIAMAB THERAPEUTICS, INC., Newton, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 16/30 (2006.01); A61K 47/48 (2006.01); A61K 47/02 (2006.01); C07K 16/44 (2006.01); A61K 9/00 (2006.01); A61K 47/12 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); A61K 9/0019 (2013.01); A61K 39/39591 (2013.01); A61K 47/02 (2013.01); A61K 47/48384 (2013.01); A61K 47/48569 (2013.01); A61K 47/48746 (2013.01); C07K 16/44 (2013.01); A61K 39/39558 (2013.01); A61K 47/12 (2013.01); A61K 2039/505 (2013.01); C07K 2317/33 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/92 (2013.01);
Abstract
The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease.